Synta Pharmaceuticals (SNTA)

Add to Watchlists Create an Alert
7.56 +0.25  +3.42%   NASDAQ May 24, 5:00PM BATS Real time Currency in USD

Synta Pharmaceuticals Cash from Financing TTM:

94.74M for March 31, 2013
View Full Chart

Synta Pharmaceuticals Cash from Financing TTM Chart

    Synta Pharmaceuticals Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 94.74M
    Dec. 31, 2012 115.52M
    Sept. 30, 2012 57.37M
    June 30, 2012 33.29M
    March 31, 2012 67.68M
    Dec. 31, 2011 36.74M
    Sept. 30, 2011 41.90M
    June 30, 2011 55.99M
    March 31, 2011 20.91M
    Dec. 31, 2010 45.16M
    Sept. 30, 2010 39.68M
       
    June 30, 2010 25.22M
    March 31, 2010 24.87M
    Dec. 31, 2009 -2.129M
    Sept. 30, 2009 -2.399M
    June 30, 2009 -2.598M
    March 31, 2009 -2.30M
    Dec. 31, 2008 -1.906M
    Sept. 30, 2008 -1.522M
    June 30, 2008 -0.939M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    SNTA Cash from Financing TTM Benchmarks

    Companies
    SurModics -57.67M
    Quest Diagnostics -784.32M
    Life Technologies -514.39M

    SNTA Cash from Financing TTM Rankings

    Overall 90th percentile
    775 of 8009
    Sector 90th percentile
    66 of 687 in Healthcare
    Industry 92nd percentile
    5 of 65 in Diagnostics & Research

    SNTA Cash from Financing TTM Range, Past 5 Years

    Minimum -2.598M Jun 2009
    Maximum 115.52M Dec 2012
    Average 32.26M